RxDoctor Payments Data

Ashley Quidaciolu, NP

Adult Health · Boca Raton, FLNPI 1245898865

Payments from drug & device makers

$810in general payments, 2019–2025

Across 27 payments — averaging $30.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$210
  • Amgen$125
  • Sanofi-aventis U.S. LLC$100
  • AbbVie$100
  • Merck$71
  • Gilead$51
  • plus $153 from 6 others

What the payments were for

  • Food & beverage$71088%
  • Education$10012%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$810 in reported general payments places this provider in the 55th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida

Medicare billing

Part B allowed, 2024
$44,508
Medicare patients
201
Services billed
350

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ActharCorticotropin13$602,589
VemlidyTenofovir Alafenamide21$30,661
Envarsus XrTacrolimus15$16,010
Cinacalcet Hcl62$14,571
Mycophenolic AcidMycophenolate Sodium27$14,132
Valganciclovir Hcl33$8,487
Tacrolimus13$1,656
Carvedilol86$1,143
Amlodipine Besylate87$758
Atorvastatin Calcium84$679
Prednisone105$676
Famotidine34$628
Labetalol Hcl19$597
Hydralazine Hcl19$585
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim44$561

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadVemlidy$51$30,66121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,237 adult health providers in Florida.

Other adult health in Boca Raton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →